Henry Connor

Title: Henry Connor - Innovator in Neurotrophic Factor Receptor Regulation

Introduction

Henry Connor is an accomplished inventor based in Absarokee, MT (US). He has made significant contributions to the field of neuroscience through his innovative work on neurotrophic factor receptors. His research focuses on methods to enhance the expression of these receptors in neurons, which can have profound implications for neurological health.

Latest Patents

Henry Connor holds a patent for a method aimed at the upregulation of TRKB and TRKC receptors in the central nervous system. The patent, titled "Method for upregulation of TRKB and TRKC receptors in central nervous," provides compositions and methods for inducing the expression of neurotrophic factor receptors trkB and trkC in neurons. The compositions include materials that activate a nuclear hormone receptor, materials that activate the second messenger response system, and materials that elevate Ca²⁺. This innovative approach has the potential to advance treatments for various neurological conditions.

Career Highlights

Henry Connor is associated with the Spinal Cord Society, where he applies his expertise in neuroscience to further research and development in the field. His work is characterized by a commitment to understanding and improving neurological health through innovative methods and technologies.

Collaborations

Henry has collaborated with notable colleagues, including Toomas Neuman and Howard O Nornes. These partnerships have enriched his research and contributed to the advancement of knowledge in neurotrophic factor receptor regulation.

Conclusion

Henry Connor's contributions to the field of neuroscience, particularly through his patent on neurotrophic factor receptors, highlight his role as an innovator dedicated to improving neurological health. His work continues to inspire advancements in the understanding and treatment of neurological disorders.